22nd Century Group (XXII) Says Phase III Study using its SPECTRUM Research Cigarettes Shows Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm

Go back to 22nd Century Group (XXII) Says Phase III Study using its SPECTRUM Research Cigarettes Shows Reduction to Very Low Nicotine is Most Likely to Lead to Less Harm
22ND CENTURY GROUP, Inc. (NYSE: XXII) Delayed: 3.91 +0.04 (1.03%)
Previous Close $3.87    52 Week High $1.71 
Open $3.92    52 Week Low $0.71 
Day High $4.00    P/E N/A 
Day Low $3.76    EPS $-0.60 
Volume 2,138,580